[DPHARMA] YoY Quarter Result on 30-Jun-2018 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
26-Nov-2018
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2018
Quarter
30-Jun-2018 [#2]
Profit Trend
QoQ- -4.11%
YoY- 7.11%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Quarter Result
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Revenue 155,439 143,331 145,466 123,991 117,049 79,135 56,308 18.42%
PBT 20,197 19,391 18,316 12,915 12,642 7,723 8,407 15.71%
Tax -4,807 -4,662 -4,400 -2,576 -3,001 -3,782 -2,559 11.06%
NP 15,390 14,729 13,916 10,339 9,641 3,941 5,848 17.48%
-
NP to SH 15,390 14,729 13,916 10,339 9,653 4,503 5,848 17.48%
-
Tax Rate 23.80% 24.04% 24.02% 19.95% 23.74% 48.97% 30.44% -
Total Cost 140,049 128,602 131,550 113,652 107,408 75,194 50,460 18.52%
-
Net Worth 614,350 581,725 503,029 209,983 463,071 446,334 189,815 21.60%
Dividend
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Div 3,530 3,421 6,618 4,199 6,973 6,973 5,582 -7.34%
Div Payout % 22.94% 23.23% 47.56% 40.62% 72.25% 154.87% 95.47% -
Equity
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Net Worth 614,350 581,725 503,029 209,983 463,071 446,334 189,815 21.60%
NOSH 706,330 684,383 661,881 650,902 278,959 278,959 139,570 30.99%
Ratio Analysis
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
NP Margin 9.90% 10.28% 9.57% 8.34% 8.24% 4.98% 10.39% -
ROE 2.51% 2.53% 2.77% 4.92% 2.08% 1.01% 3.08% -
Per Share
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
RPS 22.01 20.94 21.98 44.29 41.96 28.37 40.34 -9.59%
EPS 2.18 2.15 2.07 1.59 3.46 1.41 4.19 -10.30%
DPS 0.50 0.50 1.00 1.50 2.50 2.50 4.00 -29.26%
NAPS 0.87 0.85 0.76 0.75 1.66 1.60 1.36 -7.16%
Adjusted Per Share Value based on latest NOSH - 650,902
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
RPS 16.16 14.90 15.12 12.89 12.17 8.23 5.85 18.43%
EPS 1.60 1.53 1.45 1.07 1.00 0.47 0.61 17.41%
DPS 0.37 0.36 0.69 0.44 0.72 0.72 0.58 -7.21%
NAPS 0.6387 0.6047 0.5229 0.2183 0.4814 0.464 0.1973 21.60%
Price Multiplier on Financial Quarter End Date
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Date 30/06/21 30/06/20 28/06/19 29/06/18 30/06/17 30/06/16 30/06/15 -
Price 3.03 1.62 1.37 1.30 2.25 2.04 2.65 -
P/RPS 13.77 7.74 6.23 2.94 5.36 7.19 6.57 13.11%
P/EPS 139.03 75.27 65.16 35.20 65.02 126.38 63.25 14.01%
EY 0.72 1.33 1.53 2.84 1.54 0.79 1.58 -12.26%
DY 0.17 0.31 0.73 1.15 1.11 1.23 1.51 -30.48%
P/NAPS 3.48 1.91 1.80 1.73 1.36 1.28 1.95 10.12%
Price Multiplier on Announcement Date
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Date 17/08/21 13/08/20 30/08/19 26/11/18 25/08/17 22/08/16 25/08/15 -
Price 2.49 3.15 1.41 1.08 2.03 2.14 2.40 -
P/RPS 11.31 15.04 6.42 2.44 4.84 7.54 5.95 11.28%
P/EPS 114.25 146.36 67.06 29.25 58.66 132.57 57.28 12.18%
EY 0.88 0.68 1.49 3.42 1.70 0.75 1.75 -10.81%
DY 0.20 0.16 0.71 1.39 1.23 1.17 1.67 -29.76%
P/NAPS 2.86 3.71 1.86 1.44 1.22 1.34 1.76 8.42%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment